SLC17A9 and metabolic dysfunction-associated steatohepatitis: Furthermore, hepatic inflammation and fibrosis were markedly reduced in an HFD-induced NASH model in VNUT-knockout mice, whereas clodronate improved the pathological condition of MASLD23.